(Q51948610)

18 April 2018

title

A pilot neuropsychological study of Kraepelinian and non-Kraepelinian schizophrenia. (English)

1 reference

18 April 2018

1 reference

1 reference

8

1 reference

18 April 2018

Claudia Emond

object named as

Claudia Emond

3

0 references

author name string

Marc-André Roy

1

1 reference

18 April 2018

Catherine Lehoux

2

1 reference

18 April 2018

Louis Laplante

4

1 reference

18 April 2018

Roch-Hugo Bouchard

5

1 reference

18 April 2018

James Everett

6

1 reference

18 April 2018

Chantal Mérette

7

1 reference

18 April 2018

language of work or name

English

0 references

publication date

1 July 2003

1 reference

18 April 2018

published in

Schizophrenia Research

1 reference

18 April 2018

volume

62

1 reference

18 April 2018

issue

1-2

1 reference

18 April 2018

page(s)

155-163

1 reference

18 April 2018

The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900481-4

7 January 2021

Kraepelinian and non-Kraepelinian schizophrenia subgroup differences in cerebral metabolic rate

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900481-4

7 January 2021

Ventricular enlargement in poor-outcome schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900481-4

7 January 2021

Soft signs and neuropsychological performance in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900481-4

7 January 2021

A behavioral analysis of degree of reinforcement and ease of shifting to new responses in a Weigl-type card-sorting problem.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900481-4

7 January 2021

Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900481-4

7 January 2021

There is more than one way to collect data for linkage analysis. What a study of epilepsy can tell us about linkage strategy for psychiatric disease

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900481-4

7 January 2021

Brief neuroleptic discontinuation and clinical symptoms in Kraepelinian and non-Kraepelinian chronic schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900481-4

7 January 2021

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900481-4

7 January 2021

Characteristics of very poor outcome schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900481-4

7 January 2021

Diagnostic issues in chronic schizophrenia: kraepelinian schizophrenia, undifferentiated schizophrenia, and state-independent negative symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900481-4

7 January 2021

Clinical characteristics of Kraepelinian schizophrenia: replication and extension of previous findings

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900481-4

7 January 2021

The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900481-4

7 January 2021

Fine motor dexterity is correlated to social functioning in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900481-4

7 January 2021

Sex differences in schizophrenia, a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900481-4

7 January 2021

A modified card sorting test sensitive to frontal lobe defects

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900481-4

7 January 2021

Cognitive improvement in schizophrenia with novel antipsychotic medications

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900481-4

7 January 2021

Validity of the familial and sporadic subtypes of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900481-4

7 January 2021

Clinical and methodological factors related to reliability of the best-estimate diagnostic procedure.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900481-4

7 January 2021

Subtyping schizophrenia according to outcome or severity: a search for homogeneous subgroups

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900481-4

7 January 2021

Neurological soft signs in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900481-4

7 January 2021

Reaction time impairment in schizophrenia and affective illness: the role of attention

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900481-4

7 January 2021

Nonresponding schizophrenia: differentiation by neurological soft signs and neuropsychological tests

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900481-4

7 January 2021

The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900481-4

7 January 2021

Advances in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900481-4

7 January 2021

The case for heterogeneity in the etiology of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900481-4

7 January 2021

Schizophrenia, memory, and anticholinergic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900481-4

7 January 2021

Neurocognitive deficit in schizophrenia: a quantitative review of the evidence.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900481-4

7 January 2021

10.1016/S0920-9964(02)00481-4

Identifiers

DOI

1 reference

18 April 2018

PubMed ID

12765756

1 reference

18 April 2018